ClinicalTrials.Veeva

Menu
A

Asheville Eye Associates | Anterior Segment Research

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Aflibercept
DE-117
Timolol Maleate
KSI-301
Bimatoprost
AGN-193408
STN1013600
K-161
Tarcocimab
AXT107

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 16 total trials

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (...

Enrolling
Wet Age-related Macular Degeneration
Drug: Tarcocimab tedromer
Drug: Aflibercept

This study will demonstrate that tarcocimab 5 mg is superior to sham treatment in participants with moderately severe to severe NPDR.

Enrolling
Non-proliferative Diabetic Retinopathy
Drug: Tarcocimab
Other: Sham injection

This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the...

Enrolling
Open-angle Glaucoma
Ocular Hypertension
Other: Sham Administration
Drug: AGN-193408 SR

This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hyper...

Invitation-only
Open-Angle Glaucoma
Ocular Hypertension
Drug: Bimatoprost SR
Other: Standard of Care

The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telesc...

Enrolling
Age-Related Macular Degeneration
Geographic Atrophy
Device: smaller incision, new generation implantable miniature telescope (SING-IMT)

The goal of this clinical trial is to understand the safety of AXT107 injected suprachoroidally in participants with nAMD. The main question\[s\] it...

Active, not recruiting
Neovascular Age-related Macular Degeneration
Drug: AXT107 Mid Dose
Drug: AXT107 High Dose

Trial sponsors

Kodiak Sciences logo
S
AbbVie logo
Alcon logo
Allergan logo
A
Bayer logo
Kowa logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems